rx semaglutide SkinnyRx Semaglutide GLP-1 Weight Loss |
Description
Retatrutide is a synthetic peptide with agonist activity at the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Footnotes Clinical trial reg
But the profiles differ
While Wegovy has established a reliable foundation with average weight loss of 15% to 17%, and Mounjaro has pushed these boundaries to 22.5%, Retatrutide achieves an average of 24.2% over 48 weeks at its highest dose
Retatrutide is an investigational drug and is not FDA-approved for any indication
